DCM
LIMNW

Dupont Capital Management’s Liminatus Pharma, Inc. Warrants LIMNW Stock Holding History

Dupont Capital Management’s Portfolio LIMNW Stock Details LIMNW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$1.52K Buy
+6,250
New +$1.52K ﹤0.01% 83